drugset / Trial / NCT01443546
Study of Dual Trigger Ovulation in Oocyte Donors
Phase 4
Terminated
26 enrolled
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The project is a randomized, controlled, prospective study of oocyte donors comparing the safety and efficacy of triggering ovulation using a combination of two drugs-GnRH agonist and very low dose hCG-versus triggering ovulation with a standard hCG dose alone or a standard GnRH trigger alone.
Timeline
- Start
- 2013-01
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HCG | Unknown | 1500 iu | — |
| Subject | HCG | Unknown | 1500 iu | — |
| Subject | Leuprolide | Other / unclassified | 2 mg | Subcutaneous |